Series Tuberculosis 5 Global tuberculosis drug development pipeline: the need and the reality Zhenkun Ma, Christian Lienhardt, Helen McIlleron, Andrew J Nunn, Xiexiu Wang

First Page		Document Content
Date: 2010-05-19 10:24:07 Bacteria Tuberculosis treatment Multi-drug-resistant tuberculosis Pyrazinamide Latent tuberculosis Rifampicin Extensively drug-resistant tuberculosis Isoniazid Moxifloxacin Tuberculosis Medicine Chemistry		Series Tuberculosis 5 Global tuberculosis drug development pipeline: the need and the reality Zhenkun Ma, Christian Lienhardt, Helen McIlleron, Andrew J Nunn, Xiexiu Wang Add to Reading List Source URL: www.stoptb.org Download Document from Source Website File Size: 296,72 KB Share Document on Facebook

	Extensively drug-resistant (XDR) tuberculosis: an old and new threat Lanfranco Fattorini(a), Giovanni Battista Migliori(b) and Antonio Cassone(a) Dipartimento di Malattie Infettive, Parassitarie e Immunomediate, Istituto DocID: 1tdMY - View Document
	JOINT PRESS RELEASE For immediate release Tuberculosis cases down by 5% each year But Europe fails to cure majority of multidrug-resistant patients DocID: 1qNdf - View Document
	Microsoft Word - Uz_Success-Story_USAID ensures continued rapid TB testing in Uzbekistan_....docx DocID: 1qxcf - View Document
	FOR IMMEDIATE RELEASE Media Release Plenary Speakers announced for the 46th Union World Conference on Lung Health in Cape Town Imbizo community space featuring performance and discussion DocID: 1qukV - View Document
	989 ORIGINAL ARTICLE Prevalence and drug resistance pattern of MDR TB in retreatment cases of Punjab, Pakistan Abdul Majeed Akhtar,1 Muhammad Awais Arif,2 Shamsa Kanwal,3 Sadia Majeed4 DocID: 1q07h - View Document